// App-Quantinova.ai

: Do nonoperative modality (NOM) treatments of rectal cancer compromise the chance of cure? Final surgical salvage results from OPERA phase 3 randomised trial (NCT02505750).

Researchers

Presenter

  • Arthur Sun Myint

Principal Investigators

  • N/A

Medical Centers

  • Clatterbridge Cancer Centre, Merseyside, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT02505750

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved